FDA Releases Draft Guidance on Determining Whether to Submit an ANDA or a 505(b)(2) Application (JSON)

lexblog.com/lib/S5PCZ3HNview recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Releases Draft Guidance on Determining Whether to Submit an ANDA or a 505(b)(2) Application",
    "url": "https://www.juscorpus.com/internship-opportunity-at-neve-jewels-group/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-S5PCZ3HN",
        "url": "https://www.lexblog.com/lib/S5PCZ3HN/"
    },
    "datePublished": "2017-12-04T12:25:11-05:00",
    "dateModified": "2018-07-25T17:41:37-04:00",
    "author": {
        "@type": "Person",
        "name": "Parithosh K. Tungaturthi, Ph.D."
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Seyfarth Shaw LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "BioLoquitur",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://www.bioloquitur.com/?p=2317",
    "sourceStability": "may-move"
}